Kastus

9 results

Danalto chief executive David McDonald;   Niall McEvoy, HPSU manager at Enterprise Ireland; Tom Farrell, Danalto CTO;  Helen McBreen, investment director, Atlantic Bridge;  Albert Baker, Danalto COO and Neil Gordon, start-up development manager, Trinity College Dublin

Danalto, a Trinity College Dublin spin-out focused on internet of things (IoT) services and technologies, has raised €750,000 in seed funding The com(...)

John Browne, founder and CEO of Kastus (right) is eyeing further expansion. Photograph: Shane O’Neill Photography.

Irish firm Kastus is to “significantly increase” its workforce next year after striking a deal to supply its product to the largest manufacturer of ce(...)

Pictured is John Browne, founder and CEO of medtewch firm Kastus. Photograph: Shane O’Neill Photography

More than 70 Irish medical technology companies will seek investment from 300 international blue-chip company buyers from 42 countries on Thursday. E(...)

Dermot McCarthy, Teagasc, presenting the award for Agrifood to Jack O’Connor and Declan O’Connor from BHSL. Photograoh: Conor McCabe Photography

A pioneering antimicrobial coating that kills 99.99 per cent of harmful bugs such as MRSA, has earned young Dublin company Kastus the overall Innovati(...)

James Kennedy and Kastus founder John Browne: the firm’s antimicrobial spray coating can be applied to glass and ceramics during or after manufacture or added to plastics and paint.

Antibiotic-resistant superbugs are fast becoming one of the biggest threats to human health globally. The bugs, which include familiar names such as M(...)

Kastus founder John Browne (right) with Chris Horn of Atlantic Bridge Capital. Photograph: Shane O’Neill Photography

John Browne is the founder of precision technology company Kastus. Ten years of scientific research at Crest DIT led to the development of a novel, p(...)

Chris Horn of Atlantic Bridge Capital – which invested €1.5 million into  Kastus last December – with Kastus founder John Browne. The firm has won a Knowledge Transfer Ireland award for its advance against superbugs. Photograph: Shane O’Neill Photography

Fatal superbugs that have contributed to the deaths of patients and to outbreaks in Irish hospitals face a new enemy in the form of an award-winning a(...)

MRSA and E.coli could kill 10 million people worldwide by 2050.

Irish firm Kastus has received a €1.5 million investment as it plans its international expansion and grows its business. The investment was led by the(...)

Kastus founder, John Browne: “Our technologies have achieved industry-best Log4+ standards against MRSA and E.coli in independent laboratory tests while cytotoxicity tests have proven them not harmful to human skin.”

The long-term solution to the growing global problem of antibiotic-resistant superbugs is to build antimicrobial surfaces into product design and manu(...)